- About Us
- Programs + Admissions
- Practice Innovation
- Alumni + Donors
|Postdoctoral Position - Laboratory of Dr. Brian Rodrigues||DETAILS »|
|Postdoctoral Fellowship in Economic Evaluation of Genetic Technologies||DETAILS »|
A full-time postdoctoral position is available in the laboratory of Dr. Brian Rodrigues, Faculty of Pharmaceutical Sciences. The individual will be responsible for the design and execution of research projects involved in investigating the switch in cardiac energy supply (from glucose to fatty acid) following diabetes. Applicants must therefore have extensive knowledge and experience in various lab techniques to investigate cardiac metabolism, using animal modeling, cell culture (endothelial cells and cardiomyocyte isolation), molecular biology, and biochemistry. Applicants should have a PhD in pharmacology, biochemistry, or a related field with relevant experience.
You will be expected to take the lead role in your projects, to publish manuscripts as a first author, and to present your projects and data at lab meetings, as well as international meetings.
A high level of participation in a collaborative team setting is required, with a high level of self-motivation, excellent time management skills, ability to demonstrate creativity and sound judgment. Exemplary interpersonal and communication skills is preferred as the candidate is expected to work closely with graduate students. The candidate should demonstrate strong writing skills to ensure writing of quality scientific publications and grant applications.
You are also strongly encouraged to seek independent funding for your projects, and only competitive applicants who have the possibility to secure external sources of funding (CIHR, CDA, etc.) will be considered. Preference will be given to those with a strong publication record.
The position will remain open until filled.
Please send a curriculum vitae, a description of your research experience, a statement of your research interests, and the names of three referees to:
Dr. Brian Rodrigues
Faculty of Pharmaceutical Sciences
The University of British Columbia
2405 Wesbrook Mall, Vancouver, BC V6T 1Z3
Over the last few years, genetic technologies, and specifically genome-wide DNA sequencing, has emerged as a robust method of identifying mutations that cause hundreds of serious or life-threatening conditions in patients with previously-undiagnosed diseases. By identifying the underlying cause, this technology can provide specific information about what to expect in the future and guide access to targeted therapies that can save the lives or improve the health of people with rare genetic forms of heart, liver, kidney or bone marrow failure, developmental abnormalities, intractable seizures, metabolic diseases, rare cancers, severe adverse drug reactions, or recurrent infections of unknown cause. Although world-class researchers are using this technology in Vancouver, genome-wide sequencing is currently not available as a clinical test for most patients who need it. Economic evaluation is needed to assure equitable and cost-effective access to genomic testing, to fuel further research for better care for patients with serious genetic diseases, and to provide evidence to policy and decision makers regarding healthcare funding for certain diagnoses.
With this increasing need for economic evaluation of emerging genetic technologies and targeted therapies, we are offering a PDF training opportunity through a partnership between the CAUSES Clinic at BC Women’s and Children’s Hospital, and the Collaboration for Outcomes Research and Evaluation (CORE). The CAUSES Clinic is a pilot project to make genome-wide sequencing available to find the cause of unexplained severe diseases in British Columbia families. Its integrated multidisciplinary program will assure equitable and cost-effective access to genomic testing. The University of British Columbia’s Collaboration for Outcomes Research and Evaluation (CORE), located within the Faculty of Pharmaceutical Sciences, is a multidisciplinary group of researchers with expertise in clinical pharmacy, pharmacoepidemiology, health economics, health services research, program evaluation and health promotion research.
Applicants will have a PhD in epidemiology, health economics, health policy, health ethics/bioethics, human genetics, or a discipline related to the objective of economic evaluation of genetic technologies, with some previous experience and interests in the area. The successful applicant will be responsible for research related to the economic evaluation of the implementation of genome-wide sequencing for the diagnosis of previously undiagnosed rare genetic disorders. With this partnership, the Fellow will have a unique opportunity to be supervised and mentored by leading researchers, clinicians, and policy makers.
Applications will be accepted until the position is filled.
Preferred start date is April 2015 but is negotiable. The applicant will be required to provide a rationale and justification for applying for this Fellowship in Economic Evaluation of Genetic Technologies, and outline their specific objectives for the duration of the fellowship. Interested and qualified applicants should send curriculum vitae, a description of your research experience and most significant research accomplishments, a statement of your research interests, and the contact information for three referees via email to:
Ms. Litsa Blanis
Project Manager | Faculty of Pharmaceutical Sciences
Collaboration for Outcomes Research and Evaluation (CORE)
The University of British Columbia | Vancouver Campus
2405 Wesbrook Mall
Vancouver, BC V6T 1Z3
UBC hires on the basis of merit and are committed to employment equity. All qualified persons are encouraged to apply. We are strongly committed to diversity and welcome applications from visible minority group members, women, Aboriginal persons, persons with disabilities, persons of any sexual orientation or gender identity, and others who may contribute to the further diversification of ideas. Canadians and permanent residents of Canada will be given priority. We thank all applicants for their interest in this position. Only those selected for an interview will be contacted. However, unless informed otherwise, we will keep your application on file for one (1) year and may contact you should future job openings become available in our organizations.